Model for End-Stage Liver Disease (MELD)
The Model for End-Stage Liver Disease (MELD) is a reliable measure of mortality risk in patients with end-stage liver disease. It is used as a disease severity index to help prioritize allocation of organs for transplant.
Mayo Clinic researchers published the original MELD model in 2001. Refinements have been developed since then. These models are for use by medical professionals.
The MELD Model
The MELD-Na Model
The MELD Model, UNOS modification
MELD score and 90-day mortality rate for alcoholic hepatitis
Post-operative Mortality Risk in Patients with Cirrhosis
The Model to Estimate Survival In Ambulatory HCC Patients (MESIAH)
Probability of Mortality Following Transjugular Intrahepatic Portosystemic Shunts
See other mathematical models for liver disease patients:
The original PBC model
Updated PBC model for prediction of short-term survival
New PSC Model
A model to predict outcome of liver transplantation for PBC and PSC
The Alcoholic Liver Disease/Nonalcoholic Fatty Liver Disease Index (ANI)
Video Center image
Watch videos on advances in disease and condition treatment, procedures and surgeries, and select Grand Rounds. New presentations are added regularly.
Other Topics in Medical Professionals
Online Services for Referring Physicians
Continuing Medical Education
Mayo Medical Laboratories
.ART-20051481HomeFor Medical ProfessionalsModel for End-Stage Liver Disease (MELD)